Marijke R. Canninga‐van Dijk

Author

Also Known As

M R Canninga-van Dijk, M R Canninga‐van Dijk, M. R. Canninga-Van Dijk, M. R. Canninga-van Dijk, Marijke R Canninga-Van Dijk, Marijke R Canninga-van Dijk, Marijke R. Canninga-Van Dijk, Marijke R. Canninga-van Dijk, Marijke R. Canninga‐van Dijk

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht University Hospital Heidelberg Leiden University Medical Center Utrecht University Heidelberg University

About

Marijke R. Canninga‐van Dijk is an author at University Medical Center Utrecht specializing in medicine, cell transplantation, and ophthalmology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	453
2	Immunology	2	2	81
3	Health Sciences	1	1	22
4	Cell Biology	1	1	217
5	Neurology	1	1	24

Marijke R. Canninga‐van Dijk

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases Rein Willemze, Patty M. Jansen, Lorenzo Cerroni, Blood	2007	689
Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO–EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers Nancy J. Senff, Juliette J. Hoefnagel, Patty M. Jansen, Journal of Clinical Oncology	2007	310
Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients Marcel W. Bekkenk, Maarten H. Vermeer, Patty M. Jansen, Blood	2003	234
Loss of the Tumor Suppressor CYLD Enhances Wnt/β-Catenin Signaling through K63-Linked Ubiquitination of Dvl Daniele V. F. Tauriello, Andrea Haegebarth, Ineke Kuper, Molecular Cell K63-linked UbiquitinationSignal TransductionSignaling PathwayCell RegulationMedicine	2010	217
A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- γc-/- double-mutant mice Rozemarijn S. van Rijn, Elles Simonetti, Anton Hagenbeek, Blood	2003	180
Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease Marijke R. Canninga‐van Dijk, Hanneke M. Straaten, Rob Fijnheer, Blood	2004	129
Diagnosis of Ocular Toxocariasis by Establishing Intraocular Antibody Production Lenneke de Visser, Aniki Rothová, Joke H. de Boer, American Journal of Ophthalmology Ocular DiseaseOphthalmologyExperimental OphthalmologyHistopathologyOcular Toxocariasis	2007	109
Is the Distinction Between Superficial Pressure Ulcers and Moisture Lesions Justifiable? A Clinical‐Pathologic Study Ronald H Houwing, Jan Willem Arends, Marijke R. Canninga‐van Dijk, SKINmed Dermatology for the Clinician	2007	56
Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease C. Huisman, Hanneke M. Straaten, Marijke R. Canninga‐van Dijk, Bone Marrow Transplantation TransplantationMedicineImmunologyHematologyAutoimmunity	2006	46
Extra-Domain-A Fibronectin: A New Marker of Fibrosis in Cutaneous Graft-Versus-Host Disease Hanneke M. Straaten, Marijke R. Canninga‐van Dijk, Leo F. Verdonck, Journal of Investigative Dermatology FibrosisAutoimmune DiseaseCutaneous BiologyImmunologyCutaneous Graft-versus-host Disease	2004	35

Page 1